Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly.

导出 LinkOut

翻译打印收藏纠错

作者： Federico,Gatto ^[1] ; Claudia,Campana ^[2] ; Francesco,Cocchiara ^[3] ; Giuliana,Corica ^[2] ; Manuela,Albertelli ^[3] ; Mara,Boschetti ^[2] ; Gianluigi,Zona ^[3] ; Diego,Criminelli ^[3] ; Massimo,Giusti ^[2] ; Diego,Ferone ^[3]

作者单位： Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, 16142, Genoa, Italy. fedgatto@hotmail.it. ^[1] Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, 16142, Genoa, Italy. ^[2] Endocrinology Unit, Department of Internal Medicine and Medical Specialties (DIMI) and Centre of Excellence for Biomedical Research (CEBR), University of Genoa, 16142, Genoa, Italy. ^[3] Neurosurgery Unit, Department of Neurosciences (DINOGMI), IRCCS Ospedale Policlinico San Martino, University of Genoa, Genoa, Italy. ^[4] Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, 16142, Genoa, Italy. ferone@unige.it. ^[5] Endocrinology Unit, Department of Internal Medicine and Medical Specialties (DIMI) and Centre of Excellence for Biomedical Research (CEBR), University of Genoa, 16142, Genoa, Italy. ferone@unige.it. ^[6]

关键词 Acromegaly Biochemical control Clinical control Comorbidities Medical therapy

主题词肢端肥大症(Acromegaly);动物(Animals);共病现象(Comorbidity);女(雌)性(Female);人类(Humans);男(雄)性(Male);生活质量(Quality of Life)

DOI 10.1007/s11154-019-09506-y

PMID 31342434

发布时间 2020-04-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交